TOMBOLINI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.386
EU - Europa 703
AS - Asia 627
SA - Sud America 131
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 18
OC - Oceania 3
Totale 2.910
Nazione #
US - Stati Uniti d'America 1.348
SG - Singapore 339
RU - Federazione Russa 187
IE - Irlanda 170
BR - Brasile 117
CN - Cina 115
DE - Germania 95
VN - Vietnam 62
SE - Svezia 57
IT - Italia 46
HK - Hong Kong 40
GB - Regno Unito 34
CA - Canada 27
UA - Ucraina 25
FI - Finlandia 24
TR - Turchia 18
FR - Francia 16
BE - Belgio 13
ES - Italia 12
IN - India 12
ZA - Sudafrica 11
AR - Argentina 7
BD - Bangladesh 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
JP - Giappone 6
MX - Messico 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
NL - Olanda 4
AU - Australia 3
EU - Europa 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
ID - Indonesia 2
MA - Marocco 2
UY - Uruguay 2
UZ - Uzbekistan 2
AT - Austria 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.871
Città #
Chandler 192
Singapore 182
Dublin 170
Dallas 164
San Jose 128
Ashburn 112
Jacksonville 95
Santa Clara 52
Ann Arbor 45
Hong Kong 40
New York 39
Munich 37
The Dalles 35
Boardman 32
Council Bluffs 31
Los Angeles 23
Beijing 22
Wilmington 21
Lawrence 20
Princeton 20
Hanoi 19
Moscow 18
Ho Chi Minh City 17
São Paulo 16
Bremen 15
Orem 14
Brussels 13
Columbus 13
Nanjing 12
Helsinki 11
Izmir 10
Montreal 8
Rome 8
Stockholm 8
Woodbridge 8
Johannesburg 7
Turku 7
Atlanta 6
Brno 6
Brooklyn 6
Changsha 6
Frankfurt am Main 6
Haiphong 6
Houston 6
L'aquila 6
Manchester 6
Phoenix 6
San Mateo 6
Seattle 6
Shenyang 6
Chennai 5
Des Moines 5
Falls Church 5
Grafing 5
Kunming 5
Lappeenranta 5
Milan 5
Tokyo 5
Warsaw 5
Belo Horizonte 4
Berlin 4
Denver 4
Falkenstein 4
Mountain View 4
Nanchang 4
Poplar 4
Shanghai 4
Toronto 4
Washington 4
Boston 3
Da Nang 3
Guangzhou 3
Lauterbourg 3
Madrid 3
Mexico City 3
Mumbai 3
Norwalk 3
Ottawa 3
San Francisco 3
Ankara 2
Baghdad 2
Cape Town 2
Charlotte 2
Chicago 2
Curitiba 2
Dearborn 2
Düsseldorf 2
Guarulhos 2
Hanover 2
Hebei 2
Hefei 2
Lanzhou 2
London 2
L’Aquila 2
Montevideo 2
New Delhi 2
Philadelphia 2
Redwood City 2
Ribeirão Preto 2
Salvador 2
Totale 1.899
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 202
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 181
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 169
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 155
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 150
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 144
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 143
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 142
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 136
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 136
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 135
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 131
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 130
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 129
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 127
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 126
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 125
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 124
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 110
Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? 89
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise 71
Targeted molecular therapy in glioblastoma 55
Totale 2.910
Categoria #
all - tutte 11.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 1 29 9 3 9 7 7 18 6 8 40
2022/2023491 30 42 6 80 33 52 0 24 200 6 12 6
2023/2024138 6 14 11 5 6 60 9 2 0 5 6 14
2024/2025629 18 10 30 60 89 69 82 48 115 19 50 39
2025/20261.138 69 88 150 160 143 68 154 25 81 162 33 5
2026/202726 17 9 0 0 0 0 0 0 0 0 0 0
Totale 2.910